[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGF\u00df1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 78, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 56, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 908461, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 650708, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith J.D.", "age": 56, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.77, "open": 1.76, "dayLow": 1.72, "dayHigh": 1.876, "regularMarketPreviousClose": 1.77, "regularMarketOpen": 1.76, "regularMarketDayLow": 1.72, "regularMarketDayHigh": 1.876, "payoutRatio": 0.0, "beta": 0.441, "forwardPE": -1.4871795, "volume": 1445516, "regularMarketVolume": 1445516, "averageVolume": 3006580, "averageVolume10days": 16788700, "averageDailyVolume10Day": 16788700, "bid": 1.67, "ask": 1.85, "bidSize": 25, "askSize": 25, "marketCap": 114632768, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 2.79, "fiftyDayAverage": 1.7028, "twoHundredDayAverage": 1.15862, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 94857792, "profitMargins": 0.0, "floatShares": 34636891, "sharesOutstanding": 65880900, "sharesShort": 851154, "sharesShortPriorMonth": 122659, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0128999995, "heldPercentInsiders": 0.00358, "heldPercentInstitutions": 0.63838, "shortRatio": 1.64, "shortPercentOfFloat": 0.0269, "impliedSharesOutstanding": 65880900, "bookValue": 0.024, "priceToBook": 72.5, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -103986000, "trailingEps": -1.58, "forwardEps": -1.17, "enterpriseToEbitda": -0.959, "52WeekChange": 0.1082803, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 1.74, "targetHighPrice": 14.0, "targetLowPrice": 4.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 28131000, "totalCashPerShare": 0.427, "ebitda": -98950000, "totalDebt": 8356000, "quickRatio": 1.471, "currentRatio": 1.959, "debtToEquity": 524.874, "returnOnAssets": -0.80629, "returnOnEquity": -2.12511, "grossProfits": -2587000, "freeCashflow": -52716752, "operatingCashflow": -83326000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IOBT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.69491, "regularMarketPrice": 1.74, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755906791, "regularMarketTime": 1755892801, "exchange": "NMS", "messageBoardId": "finmb_1685354464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.58, "epsForward": -1.17, "epsCurrentYear": -1.1, "priceEpsCurrentYear": -1.5818181, "fiftyDayAverageChange": 0.037199974, "fiftyDayAverageChangePercent": 0.021846356, "twoHundredDayAverageChange": 0.58138, "twoHundredDayAverageChangePercent": 0.5017866, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-05", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "postMarketChangePercent": 1.1494242, "postMarketPrice": 1.76, "postMarketChange": 0.01999998, "regularMarketChange": -0.03, "regularMarketDayRange": "1.72 - 1.876", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3006580, "fiftyTwoWeekLowChange": 1.0799999, "fiftyTwoWeekLowChangePercent": 1.6363635, "fiftyTwoWeekRange": "0.66 - 2.79", "fiftyTwoWeekHighChange": -1.05, "fiftyTwoWeekHighChangePercent": -0.37634408, "fiftyTwoWeekChangePercent": 10.82803, "earningsTimestampStart": 1747224300, "earningsTimestampEnd": 1747224300, "displayName": "IO Biotech", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]